Zynext Ventures Logo
  • Home
  • About Us
  • Our Approach
  • Team
  • Portfolio
  • News and Insights
  • Contact Us
Zynext Ventures Logo
  • Home
  • About Us
  • Our Approach
  • Team
  • Portfolio
  • News and Insights
  • Contact Us
  • All

  • News

  • Insights

Zynext Ventures invests in Feldan Therapeutics

Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery

Read More

Zynext Ventures invests in Illexcor Therapeutics

Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease

Read More

Zynext Ventures invests in Neuro42

Zynext Ventures invests in neuro42, A Company Developing Portable MRI Systems for Neuroimaging and Interventions.

Read More

Zynext Ventures invests in Promaxo

Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo: Pioneering Point-of-Care Medical Imaging and Interventions with Next Generation MRI Systems

Read More

First drug approval for NASH

Rezdiffra was approved under the accelerated approval pathway for the treatment of adults with NASH with moderate to advanced liver scarring, to be used along with diet and exercise.

Read More

Cell and gene Therapy in rampage but expensive affair

Cell and gene therapy (CGT) provides advanced medical treatments that revolutionise the approach and treatments where traditional pharma and small-molecule drugs are not viable.

Read More

Zynext Ventures invests in Feldan Therapeutics

Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery

Read More

Zynext Ventures invests in Illexcor Therapeutics

Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease

Read More

Zynext Ventures Invests in Neuro42

Zynext Ventures Invests in neuro42, A Company Developing Portable MRI Systems for Neuroimaging and Interventions.

Read More

Zynext Ventures invests in Promaxo

Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo: Pioneering Point-of-Care Medical Imaging and Interventions with Next Generation MRI Systems

Read More

First drug approval for NASH

Rezdiffra was approved under the accelerated approval pathway for the treatment of adults with NASH with moderate to advanced liver scarring, to be used along with diet and exercise.

Read More

Cell and gene Therapy in rampage but expensive affair

Cell and gene therapy (CGT) provides advanced medical treatments that revolutionise the approach and treatments where traditional pharma and small-molecule drugs are not viable.

Read More